Alphyn Biologics, Inc.
Publicly observedAnnapolis, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Annapolis | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Alphyn Biologics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | RXCWG3EDWUT8 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant14 Sept 2026Publicly observed
NIH SBIR/STTR award: AB-101: A Multi-Target Botanical Hydrogel for Combating Antimicrobial Resistance in Atopic Dermatitis
USD 1,100,000.00 · National Center for Complementary and Integrative Health · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.